about
Colonoscopy quality: metrics and implementationPreventing upper gastrointestinal bleeding in patients with Helicobacter pylori infectionThrough-the-scope balloon dilation for endoscopic ultrasound staging of stenosing esophageal cancerA method of assessing the adequacy of trucut biopsy specimens obtained with a 19-gauge trucut core biopsy needle.Body-mass index and symptoms of gastroesophageal reflux in women.A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis.Body mass index and the efficacy of acid-mediating agents for GERD.Postmenopausal hormone use and symptoms of gastroesophageal refluxThe inaccuracy of ICD-9-CM Code 530.2 for identifying patients with Barrett's esophagusBody mass index and Barrett's oesophagus in women.Comprehensive validation of the Boston Bowel Preparation ScaleAn endoscopist-blinded, randomized, controlled trial of a simple visual aid to improve bowel preparation for screening colonoscopy.A lexicon for endoscopic adverse events: report of an ASGE workshop.Grading the complexity of endoscopic procedures: results of an ASGE working party.Multiple asymptomatic plexiform schwannomas of the sigmoid colon: a case report and review.Quality indicators for colonoscopy.Smoking and Barrett's esophagus in women who undergo upper endoscopy.Enhanced endoscopy in inflammatory bowel disease.Guidelines for antibiotic prophylaxis for GI endoscopy.Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy.Obscure gastrointestinal bleeding.The role of EUS for evaluation of mediastinal adenopathy.Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort studyASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer.ASGE guideline: complications of EUS.ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures.Quality indicators for gastrointestinal endoscopic procedures: an introduction.Quality indicators for esophagogastroduodenoscopy.Quality indicators for endoscopic retrograde cholangiopancreatography.Quality indicators for endoscopic ultrasonography.Gastrointestinal epithelial dysplasia: detection with new endoscopic techniques.Gastroenterologists' experience with the 2007 Physician Quality Reporting Initiative: a demonstration project.The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research.Acute pancreatitis associated with rofecoxib.Endoscopic ultrasound-guided gallbladder bile aspiration in idiopathic pancreatitis carries a significant risk of bile peritonitis.Barrett's esophagus: prevalence-incidence and etiology-origins.Guidelines for the use of deep sedation and anesthesia for GI endoscopy.Reliability of adenoma detection rate is based on procedural volume.Who is using chronic acid suppression therapy and why?Posttransplantation lymphoproliferative disorder of the stomach.
P50
Q26865934-DDF092E7-1605-4E46-85A5-D1F4631EA7EDQ28186185-45CDB80E-DD9D-4B94-ADA7-45BCB4ACED36Q30435201-F524A342-815D-4298-AC8D-4C2F3BC205FAQ33239728-6BBFCF8F-0726-4FF0-B5F8-0CD1D7B700C5Q33245320-A2C0D9C7-D87B-41F9-8827-5B92E970A0B4Q33290036-A174C461-F3C5-4F39-A01D-C73E081C3643Q33352124-5854EAF1-0588-4BAB-A97E-B1C044CB70F4Q33367895-299C8D27-881E-4460-ACC8-B86339A4BA22Q33397810-DB76CB9A-729C-4050-AF87-DBE702725003Q33425118-8D78209D-ED10-41D7-B812-DC07026FB779Q33706753-9EA2EF31-4433-4F0D-975E-F9E24BC63E52Q33775130-2E9E18AC-9684-4354-AE04-90FAD4C6FB39Q34101032-2D460E93-C74D-4C6B-844D-E49CEDB43094Q34168765-6E3EAEA8-F628-4E19-B4D5-A55D48BED269Q34262984-CE4C4331-83E8-45D0-B400-57C306D1D82DQ34517049-73F77D53-F8ED-421B-860D-2B49AB6EBA95Q35000990-B7FE3BF4-10B7-4277-A80E-FCA52F08230AQ35027720-CC4E07F8-CF2F-4B3B-A043-13573855E754Q35547699-D8CB8DFB-198D-40F6-83BF-F1C1522198C7Q35551040-5CF73A2E-9197-4BED-A3DD-374166C867DCQ35574502-2FB4C5A3-3EBF-4050-91BB-7224767554FEQ35599082-57B30152-C4E3-442B-8B0C-EB223B5933E5Q35719101-083D2D25-58AE-4C20-AC24-41486A96D863Q36020689-65C8A25C-EE89-4977-AEA8-546811E31716Q36020693-0579018D-FD38-4B44-A044-B5FE240A398BQ36053595-CF9B1E59-19DD-48C0-864A-2B64E0B5552AQ36431904-D6F56251-0AF5-4173-9A08-D3A080A9E57BQ36431909-74E9C852-2805-4E9B-9A08-61185559D260Q36431916-BFB894C9-681C-402F-8DBA-4C1FC2B7FB10Q36431920-71E6D638-2D97-4B23-8B7D-A57973224816Q36620180-3F905358-9DE8-4FD9-BA7B-CF8A7A6C4F10Q37388613-942F5D5E-ED1E-4825-8F8B-4340FAECDD14Q37392109-438BB901-BF73-4A19-8128-08F9A1898A78Q43988187-342559F8-16B2-4D12-9469-7A2284D2638EQ44065322-9370DF96-146B-49A6-888B-403E25B55FA7Q44130284-E196E6BD-42F4-4BE3-B66C-FD1189FE194AQ44192159-7374E2AC-C58F-488C-88B9-78737344E361Q44264243-9FC3A73B-2862-42BB-9779-7D1B06009BA7Q44277473-0C0DB2BB-D6B1-4001-8EC2-27F21E5612EFQ44487988-B1611421-5CE2-4370-87EF-0A5718BF9085
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brian Jacobson
@ast
Brian Jacobson
@en
Brian Jacobson
@es
Brian Jacobson
@nl
Brian Jacobson
@sl
Брайан Якобсон
@ru
type
label
Brian Jacobson
@ast
Brian Jacobson
@en
Brian Jacobson
@es
Brian Jacobson
@nl
Brian Jacobson
@sl
Брайан Якобсон
@ru
prefLabel
Brian Jacobson
@ast
Brian Jacobson
@en
Brian Jacobson
@es
Brian Jacobson
@nl
Brian Jacobson
@sl
Брайан Якобсон
@ru
P106
P21
P31
P496
0000-0001-7064-2357